According to Galectin Therapeutics's latest financial reports the company's total assets are โน2.49 Billion. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | โน1.76 B | -43.42% |
2021-12-31 | โน3.11 B | 43.81% |
2020-12-31 | โน2.16 B | -37.37% |
2019-12-31 | โน3.45 B | 448.85% |
2018-12-31 | โน0.62 B | 137.02% |
2017-12-31 | โน0.26 B | -75.25% |
2016-12-31 | โน1.07 B | -38.84% |
2015-12-31 | โน1.75 B | -6.7% |
2014-12-31 | โน1.88 B | 184.18% |
2013-12-31 | โน0.66 B | 26.43% |
2012-12-31 | โน0.52 B | 49.67% |
2011-12-31 | โน0.34 B | 23.9% |
2010-12-31 | โน0.28 B | 1295.44% |
2009-12-31 | โน20.23 M | -40.21% |
2008-12-31 | โน33.83 M | -51.62% |
2007-12-31 | โน69.93 M | -75.18% |
2006-12-31 | โน0.28 B | 26.19% |
2005-12-31 | โน0.22 B | -53.58% |
2004-12-31 | โน0.48 B | 32.06% |
2003-12-31 | โน0.36 B | 232.76% |
2002-12-31 | โน0.10 B | 28.45% |
2001-12-31 | โน85.23 M |